Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction.
Sci Rep
; 13(1): 9825, 2023 06 17.
Article
in En
| MEDLINE
| ID: mdl-37330528
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Interleukin-1 Receptor-Like 1 Protein
/
Inflammation
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Sci Rep
Year:
2023
Type:
Article
Affiliation country:
United kingdom